Digestive & Intestinal Remedies (Pharmacies) - Guyana

  • Guyana
  • Revenue in the Digestives & Intestinal Remedies market is projected to reach US$6.19m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 11.62%, resulting in a market volume of US$9.61m by 2028.
  • In global comparison, most revenue will be generated in China (US$3,367.00m in 2024).
  • In relation to total population figures, per person revenues of US$7.55 are generated in 2024.

Key regions: United States, South Korea, Japan, Canada, India

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Digestive & Intestinal Remedies (Pharmacies) market in Guyana is experiencing steady growth due to changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestive & Intestinal Remedies market have shifted towards natural and herbal remedies, as consumers become more health-conscious and seek alternative options to traditional pharmaceutical products. This trend is not unique to Guyana, but is seen worldwide as consumers prioritize natural ingredients and holistic approaches to healthcare. As a result, there is a growing demand for herbal digestive remedies in Guyana, such as herbal teas and supplements, which are believed to have fewer side effects and offer a more gentle approach to treating digestive issues. In addition to customer preferences, several trends are driving the growth of the Digestive & Intestinal Remedies market in Guyana. One such trend is the increasing prevalence of digestive disorders, including acid reflux, indigestion, and irritable bowel syndrome. These conditions are often caused by poor diet, stress, and sedentary lifestyles, which are common in modern society. As a result, there is a growing need for effective and accessible remedies to alleviate these symptoms, leading to an increased demand for Digestive & Intestinal Remedies in pharmacies. Another trend in the market is the rising popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They help restore the natural balance of bacteria in the gut and promote healthy digestion. Probiotics can be found in various forms, including supplements, yogurts, and fermented foods. The increasing awareness of the benefits of probiotics has led to a surge in demand for these products in the Digestive & Intestinal Remedies market in Guyana. Local special circumstances also contribute to the growth of the Digestive & Intestinal Remedies market in Guyana. The country has a high prevalence of gastrointestinal diseases, which can be attributed to factors such as poor sanitation, inadequate access to clean water, and a lack of awareness about proper hygiene practices. These circumstances have created a significant market for Digestive & Intestinal Remedies as consumers seek solutions to alleviate their symptoms and improve their overall digestive health. Underlying macroeconomic factors, such as increasing disposable income and a growing middle class, have also played a role in the development of the Digestive & Intestinal Remedies market in Guyana. As people have more money to spend on healthcare, they are more likely to invest in remedies and products that can improve their digestive health. Additionally, the expansion of the pharmaceutical industry in Guyana has led to a wider availability of Digestive & Intestinal Remedies in local pharmacies, making them more accessible to consumers. In conclusion, the Digestive & Intestinal Remedies market in Guyana is experiencing growth due to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. As consumers prioritize natural remedies, seek relief from digestive disorders, and become more aware of the benefits of probiotics, the demand for Digestive & Intestinal Remedies continues to rise in Guyana.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)